894 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... normal range (KDIGO ... hypercalcemia (KDIGO ... Purposes Only* #CKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... , AKD Acute Kidney ... Kidney Disease (CKD ... /CKD • No structural ... damage #AKI #CKD
KDIGO Definition of Acute Kidney Injury (AKI)

#Diagnosis #Nephrology #KDIGO #AKI #Acute #Kidney #Injury
KDIGO Definition ... Diagnosis #Nephrology #KDIGO
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... ADA/KDIGO Consensus ... 2 diabetes and CKD ... #Diabetes #CKD # ... ADA #KDIGO #eGFR
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Management in CKD ... Gout #Management #CKD ... rheumatology #treatment #comparison
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... SGLT2i in HF and CKD ... kidney events in CKD ... patients with CKD
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
#Metformin #CKD ... algorithm #management #kdigo
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
medications in CKD ... Pharmacokinetics #halflife #comparison
Effects of Prostaglandins and NSAIDs on the Kidney
Effects of Prostaglandins on the Kidney:
 • The vasodilatory
is increased in CKD ... modest GFR • KDIGO ... prolonged NSAID use in CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Improved outcomes in CKD ... medications #table #comparison